ATE282622T1 - Kondensierte pyrazolverbindungen - Google Patents

Kondensierte pyrazolverbindungen

Info

Publication number
ATE282622T1
ATE282622T1 AT02250490T AT02250490T ATE282622T1 AT E282622 T1 ATE282622 T1 AT E282622T1 AT 02250490 T AT02250490 T AT 02250490T AT 02250490 T AT02250490 T AT 02250490T AT E282622 T1 ATE282622 T1 AT E282622T1
Authority
AT
Austria
Prior art keywords
independently
pyrazole compounds
condensed pyrazole
compounds
compound
Prior art date
Application number
AT02250490T
Other languages
English (en)
Inventor
Kuo Sheng-Chu
Fang Yu Lee
Che-Ming Teng
Original Assignee
Yung Shin Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yung Shin Pharmaceutical Ind filed Critical Yung Shin Pharmaceutical Ind
Application granted granted Critical
Publication of ATE282622T1 publication Critical patent/ATE282622T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02250490T 2001-01-24 2002-01-24 Kondensierte pyrazolverbindungen ATE282622T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26378201P 2001-01-24 2001-01-24

Publications (1)

Publication Number Publication Date
ATE282622T1 true ATE282622T1 (de) 2004-12-15

Family

ID=23003205

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02250490T ATE282622T1 (de) 2001-01-24 2002-01-24 Kondensierte pyrazolverbindungen
AT03078987T ATE347556T1 (de) 2001-01-24 2002-01-24 Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03078987T ATE347556T1 (de) 2001-01-24 2002-01-24 Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck

Country Status (7)

Country Link
US (1) US6518294B2 (de)
EP (1) EP1227099B1 (de)
CN (1) CN1393446B (de)
AT (2) ATE282622T1 (de)
CA (1) CA2369232C (de)
DE (2) DE60201921T2 (de)
TW (1) TWI250161B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077702A1 (en) * 2001-09-14 2004-04-22 Wen-Mei Fu Treatment of nuerodegenerative diseases
US7345079B2 (en) * 2001-12-26 2008-03-18 Yung Shin Pharmaceuticals Industrial Co., Ltd Treatment of disorder related to low cyclic GMP levels
CA2473886C (en) * 2002-01-22 2012-08-21 The Regents Of The University Of California Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
US7166293B2 (en) * 2002-03-29 2007-01-23 Carlsbad Technology, Inc. Angiogenesis inhibitors
US20050096370A1 (en) * 2003-04-07 2005-05-05 Bizbiotech Co., Ltd. Method for inhibiting tumor angiogenesis and tumor growth
JP4499721B2 (ja) 2003-06-30 2010-07-07 ヒフ バイオ，インク． 化合物、組成物および方法
WO2005058911A2 (en) * 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
GB0405933D0 (en) * 2004-03-16 2004-04-21 Glaxo Group Ltd Compounds
CN100516049C (zh) * 2004-11-16 2009-07-22 永信药品工业股份有限公司 抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
WO2007025303A2 (en) * 2005-08-26 2007-03-01 The Regents Of The University Of California Non-steroidal antiandrogens
US20080252028A1 (en) * 2007-04-16 2008-10-16 Ming-Tai Huang Shock absorbing device for toy stroller

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 １−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途
DE19642255A1 (de) 1996-10-14 1998-04-16 Bayer Ag Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten
IT1295384B1 (it) 1997-10-23 1999-05-12 Snam Progetti Rivestimento protettivo di apparecchiature a pressione utilizzabili in processi per la sintesi dell'urea
US6387942B2 (en) 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation

Also Published As

Publication number Publication date
DE60216610D1 (de) 2007-01-18
TWI250161B (en) 2006-03-01
CN1393446A (zh) 2003-01-29
HK1050194A1 (zh) 2003-06-13
CA2369232C (en) 2010-05-25
CN1393446B (zh) 2010-06-16
CA2369232A1 (en) 2002-07-24
DE60201921T2 (de) 2005-10-06
DE60216610T2 (de) 2007-10-11
US6518294B2 (en) 2003-02-11
EP1227099A1 (de) 2002-07-31
US20030004355A1 (en) 2003-01-02
EP1227099B1 (de) 2004-11-17
ATE347556T1 (de) 2006-12-15
DE60201921D1 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
ATE319446T1 (de) Neue prolinverbindungen als mikrobizide mittel
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DK0418845T3 (da) Pyrazolderivater, fremgangsmåder til fremstilling deraf og farmaceutisk præparat omfattende samme
NO913750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
ATE404561T1 (de) Neue adeninderivate
WO2001009103A3 (en) Imidazole antiproliferative agents
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
EP1533304A4 (de) Amidderivat
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
DE60328035D1 (de) Neue azolderivate
ATE282622T1 (de) Kondensierte pyrazolverbindungen
WO2003064429A1 (en) Thienopyrimidines, process for preparing the same and use thereof
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
ATE259376T1 (de) Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren
ATE402151T1 (de) 2-(arylphenyl)amino-imidazolin-derivate
EP0921122A4 (de) Neue epoxysuccinamid-derivate oder ihre salze
WO2003031414A1 (en) Novel heterocyclic compound and anti-inflammatory agent
CA2262997A1 (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
DE69226931D1 (de) Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
WO2003027077A1 (en) Water-soluble phenylpyridazine derivatives and drugs containing the same
DE60001205D1 (de) Azolderivative oder deren Salze
WO2002026230A1 (en) Remedies for inflammatory bowel diseases
IL155183A (en) Oxapenam - 3 - Carboxylic acids, pharmaceutical preparations containing it and their use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties